Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | Wide-scale implementation of precision medicine

Kjetil Tasken • 11 Sep 2022
ESMO 2022
General

Kjetil Tasken, MD, PhD, University of Oslo, Oslo, Norway, discusses precision cancer medicine initiatives being developed in Europe and the importance of patients being able to access gene panel testing in order to receive personalised treatments. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Kjetil Tasken

0:51
Data aggregation across clinical trials
Kjetil Tasken • 11 Sep 2022
4:56
Implementing a precision cancer medicine initiative in Norway
Kjetil Tasken • 11 Sep 2022

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals